Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels

Table 1 Patient baseline characteristics

Variables	High baseline ALT group	Controls
Patients (n)	40	40
Male, n (%)	29 (72.5)	28 (70)
Age (yr, mean ± SD)	28.12 ± 3.71	31.12 ± 5.43
ALT (IU/L)	885.6 ± 7.89	128.4 ± 5.33
TBiL (μmol/L)	45.43 ± 6.67	29.12 ± 2.56
HBV DNA (copies/mL)
Median	7.78 × 108	7.56 × 108
Range	4.67 × 105-8.58 × 109	5.89 × 105-7.34 × 109

ALT: Alanine aminotransferase; TBiL: Total bilirubin; HBV: Hepatitis B virus.